Such IDH mutations are already present in diffuse or anaplastic astrocytomas that represent precursor lesions of secondary glioblastomas [6,7] and they further induce extensive DNA hypermethylation known as the glioma-CpG island methylator phenotype (G-CIMP) [10,11]. Here, IDH1 is linked to central nervous system cancer.